On August 24, 2026, Japan’s Ministry of Health, Labour and Welfare approved bepirovirsen (development code GSK3228836, commonly abbreviated as GSK836), developed by GSK and marketed under the brand name Hibsago, for functional cure in eligible adults with persistent hepatitis B virus infection. ...
Dyslipidemia is a metabolic condition characterized by abnormal plasma lipid or lipoprotein levels. Persistently elevated LDL-C, triglyceride-rich lipoproteins and their remnants, and lipoprotein(a) [Lp(a)] can all promote atherosclerotic cardiovascular disease. In addition to traditional ...
A miRNA antagomir is an antisense oligonucleotide tool used to inhibit the function of a specific miRNA. It is commonly used to construct miRNA loss-of-function models, validate target gene derepression effects, and analyze the regulatory roles of miRNAs in disease development, cell ...